Dynamic Advisor Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
DC
CTB
CNB
GIA
MLL
AP
COPPSERS
Dynamic Advisor Solutions's VRTX Position: Q2 2026 in Review
Dynamic Advisor Solutions reduced its Vertex Pharmaceuticals (VRTX) stake by 16% in Q2 2026, selling an estimated $250K and leaving 2,984 shares worth $1.48M. The position accounts for 0.04% of the portfolio, ranked #396.
Dynamic Advisor Solutions first reported a position in VRTX in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.9M in Q2 2024. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Dynamic Advisor Solutions held 2,984 shares of Vertex Pharmaceuticals worth $1.48M as of Q2 2026.
- Dynamic Advisor Solutions sold 565 Vertex Pharmaceuticals shares in Q2 2026, an estimated $250K.
- Vertex Pharmaceuticals made up 0.04% of Dynamic Advisor Solutions's portfolio in Q2 2026, its #396 holding.
- Dynamic Advisor Solutions first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
- Dynamic Advisor Solutions's Vertex Pharmaceuticals position peaked at $2.9M in Q2 2024.
- 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Dynamic Advisor Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.